Statistical controversies in clinical research: basket trials, umbrella trials, and other master protocols: a review and examples
Lindsay Anne Renfro, Daniel J. Sargent · Annals of Oncology · 2016
Cited by 271 works. doi:10.1093/annonc/mdw413 Open-access PDF
Authors
References
- PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
- Adverse Renal Effects of Immune Checkpoint Inhibitors: A Narrative Review
- Use of Chemotherapy plus a Monoclonal Antibody against HER2 for Metastatic Breast Cancer That Overexpresses HER2
- Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
- Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer
- Pembrolizumab versus Ipilimumab in Advanced Melanoma
- Inhibition of Mutated, Activated BRAF in Metastatic Melanoma
- Cancer Genome Landscapes
- A New Initiative on Precision Medicine
- Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase 3 study